Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

Stoke Therapeutics (STOK) Receivables - Net (2024 - 2025)

Stoke Therapeutics has reported Receivables - Net over the past 2 years, most recently at $5.9 million for Q4 2025.

  • Quarterly results put Receivables - Net at $5.9 million for Q4 2025, up 255.88% from a year ago — trailing twelve months through Dec 2025 was $5.9 million (up 255.88% YoY), and the annual figure for FY2025 was $5.9 million, up 255.88%.
  • Receivables - Net for Q4 2025 was $5.9 million at Stoke Therapeutics, down from $9.2 million in the prior quarter.
  • Over the last five years, Receivables - Net for STOK hit a ceiling of $9.2 million in Q3 2025 and a floor of $1.7 million in Q4 2024.